✦ LIBER ✦

A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia

✍ Scribed by Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Gohei Yagi; Haruo Kashima

Book ID: 116840304
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 180 KB
Volume: 28
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2003.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An unblinded comparison of the clinical

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia

✍ Hidenobu Suzuki; Keishi Gen; Yuichi Inoue 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 198 KB

PMH43 THE IMPACT OF A FORMULARY EXPANSIO

PMH43 THE IMPACT OF A FORMULARY EXPANSION TO INCLUDE ADDITION OF SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS ON THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA

✍ P Mulani; J McCombs 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

The impact upon extra-pyramidal side eff

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,